A Retrospective study of (sirolimus) mTOR-based immunosuppression and risk of cytomegalovirus infection in liver transplant patients
Latest Information Update: 12 May 2017
At a glance
- Drugs Sirolimus (Primary) ; Calcineurin inhibitors
- Indications Liver transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 12 May 2017 New trial record
- 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases